IP Library › Granted Patent US 8,236,559
Granted Patent B2
US 8,236,559 · App. 12/210,313 · Granted Aug 7, 2012

Therapeutic human anti-IL-1R1 monoclonal antibody

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,236,559
App. No.
12/210,313
Granted
Aug 7, 2012
Kind
B2
Abstract

Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described.

Claims (62)

1. An isolated nucleic acid molecule comprising:

(a) nucleotide sequences encoding human heavy chain framework regions, a nucleotide sequence encoding a human heavy chain CDR1 region comprising SEQ ID NO: 63, a nucleotide sequence encoding a human heavy chain CDR2 region comprising SEQ ID NO: 66, and a nucleotide sequence encoding a human heavy chain CDR3 region comprising SEQ ID NO: 69; and

(b) nucleotide sequences encoding human light chain framework regions, a nucleotide sequence encoding a human light chain CDR1 region comprising SEQ ID NO: 71, a nucleotide sequence encoding a human light chain CDR2 region comprising SEQ ID NO: 73, and a nucleotide sequence encoding a human light chain CDR3 region comprising SEQ ID NO: 75.

2. An isolated nucleic acid molecule comprising a nucleotide sequence encoding a human antibody or an antigen-binding fragment thereof that specifically binds interleukin-1 receptor type 1 (IL-1R1), wherein the antibody or fragment thereof comprises:

(a) a heavy chain variable region comprising the amino acid sequence encoded by SEQ ID NO: 15, or the amino acid sequences of SEQ ID NO: 63, SEQ ID NO: 66, and SEQ ID NO: 69; and

(b) a light chain variable region comprising the amino acid sequence encoded by SEQ ID NO: 17, or the amino acid sequences of SEQ ID NO: 71, SEQ ID NO: 73 and SEQ ID NO: 75.

3. The isolated nucleic acid molecule of claim 1 , wherein the isolated nucleic acid molecule comprises a combination of nucleic acid sequences that encode a heavy chain variable region and a light chain variable region of an antibody that specifically binds IL-1R1, wherein the combination comprises: SEQ ID NO: 85 and SEQ ID NO: 86.

4. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes a human antibody that specifically binds IL-1R1, wherein the antibody comprises a heavy chain having a heavy chain variable region, or an antigen-binding fragment thereof, wherein the heavy chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 15, and wherein the antigen-binding fragment comprises an N-terminal or C-terminal deletion of the amino acid sequence encoded by SEQ ID NO: 15, wherein the N-terminal or C-terminal deletion comprises SEQ ID NO: 63, SEQ ID NO: 66, and SEQ ID NO: 69.

5. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes a human antibody that specifically binds IL-1R1, wherein the antibody comprises a light chain having a light chain variable region, or an antigen-binding fragment thereof, wherein the light chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 17, and wherein the antigen-binding fragment comprises an N-terminal or C-terminal deletion of the amino acid sequence encoded by SEQ ID NO: 17, wherein the N-terminal or C-terminal deletion comprises SEQ ID NO: 71, SEQ ID NO: 73, and SEQ ID NO: 75.

6. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes a human antibody that specifically binds IL-1R1, wherein the antibody comprises a heavy chain having a heavy chain variable region, or an antigen-binding fragment thereof, wherein the heavy chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 85, and wherein the antigen-binding fragment comprises an N-terminal or C-terminal deletion of the amino acid sequence encoded by SEQ ID NO: 85, wherein the N-terminal or C-terminal deletion comprises SEQ ID NO: 63, SEQ ID NO:66, and SEQ ID NO: 69.

7. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes a human antibody that specifically binds IL-1R1, wherein the antibody comprises a light chain having a light chain variable region, or an antigen-binding fragment thereof, wherein the light chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 86, and wherein the antigen-binding fragment comprises an N-terminal or C-terminal deletion of the amino acid sequence encoded by SEQ ID NO: 86, wherein the N-terminal or C-terminal deletion comprises SEQ ID NO: 71, SEQ ID NO: 73, and SEQ ID NO: 75.

8. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes a human antibody that specifically binds IL-1R1, wherein the antibody comprises a heavy chain having a heavy chain variable region, or an antigen-binding fragment thereof, wherein the heavy chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 85, and wherein the antigen-binding fragment comprises SEQ ID NO: 63, SEQ ID NO: 66, and SEQ ID NO: 69 and wherein the antibody comprises a light chain having a light chain variable region, or an antigen-binding fragment thereof, wherein the light chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 86, and wherein the antigen-binding fragment comprises SEQ ID NO: 71, SEQ ID NO: 73, and SEQ ID NO: 75.

9. The isolated nucleic acid molecule of either of claims 3 or 8 wherein the nucleic acid molecule encodes an antibody that is an IgG2 antibody.

10. The isolated nucleic acid molecule of either of claims 3 or 8 , wherein the nucleic acid molecule encodes an antibody that is a fully human antibody.

11. A vector comprising the nucleic acid molecule of any of claims 1 - 3 , and 4 - 8 .

12. A vector comprising the nucleic acid molecule of claim 9 .

13. A vector comprising the nucleic acid molecule of claim 10 .

14. An expression vector comprising the nucleic acid molecule of any of claims 1 - 3 , and 4 - 8 .

15. An expression vector comprising the nucleic acid molecule of claim 9 .

16. An expression vector comprising the nucleic acid molecule of claim 10 .

17. An isolated host cell comprising the vector of claim 11 .

18. An isolated host cell comprising the expression vector of claim 14 .

19. The host cell of claim 17 that is a eukaryotic cell.

20. The host cell of claim 17 that is a prokaryotic cell.

21. The host cell of claim 18 that is a eukaryotic cell.

22. The host cell of claim 18 that is a prokaryotic cell.

23. A cell line comprising the expression vector of claim 14 .

24. A set of nucleic acid molecules comprising:

(a) a first nucleic acid molecule encoding human heavy chain framework regions, a nucleotide sequence encoding a human heavy chain CDR1 region comprising SEQ ID NO: 63, a nucleotide sequence encoding a human heavy chain CDR2 region comprising SEQ ID NO: 66, and a nucleotide sequence encoding a human heavy chain CDR3 region comprising SEQ ID NO: 69; and

(b) a second nucleic acid molecule encoding human light chain framework regions, a nucleotide sequence encoding a human light chain CDR1 region comprising SEQ ID NO: 71, a nucleotide sequence encoding a human light chain CDR2 region comprising SEQ ID NO: 73, and a nucleotide sequence encoding a human light chain CDR3 region comprising SEQ ID NO: 75.

25. A set of nucleic acid molecules comprising:

(a) a first nucleic acid molecule encoding a human antibody heavy chain variable region comprising the amino acid sequence encoded by SEQ ID NO: 15, or the amino acid sequences of SEQ ID NO: 63, SEQ ID NO: 66, and SEQ ID NO: 69; and

(b) a second nucleic acid molecule encoding a human antibody light chain variable region comprising the amino acid sequence encoded by SEQ ID NO: 17, or the amino acid sequences of SEQ ID NO: 71, SEQ ID NO: 73 and SEQ ID NO: 75.

26. The set of nucleic acid molecules of claim 24 , wherein the first nucleic acid molecule comprises SEQ ID NO: 85 and the second nucleic acid molecule comprises SEQ ID NO: 86.

27. A set of nucleic acid molecules comprising nucleotide sequences that encode a human antibody that specifically binds IL-1R1, comprising:

(a) a first nucleic acid molecule encoding a human antibody heavy chain having a heavy chain variable region, or an antigen-binding fragment thereof, wherein the heavy chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 15, and wherein the antigen-binding fragment comprises an N-terminal or C-terminal deletion of the amino acid sequence encoded by SEQ ID NO: 15, wherein the N-terminal or C-terminal deletion comprises SEQ ID NO: 63, SEQ ID NO: 66, and SEQ ID NO: 69; and

(b) a second nucleic acid molecule encoding a human antibody light chain.

28. A set of nucleic acid molecules comprising nucleotide sequences that encode a human antibody that specifically binds IL-1R1, comprising:

(a) a first nucleic acid molecule encoding a human antibody heavy chain; and

(b) a second nucleic acid molecule encoding a human antibody light chain having a light chain variable region, or an antigen-binding fragment thereof, wherein the light chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 17, and wherein the antigen-binding fragment comprises an N-terminal or C-terminal deletion of the amino acid sequence encoded by SEQ ID NO: 17, wherein the N-terminal or C-terminal deletion comprises SEQ ID NO: 71, SEQ ID NO: 73, and SEQ ID NO: 75.

29. A set of nucleic acid molecules comprising nucleotide sequences that encode a human antibody that specifically binds IL-1R1, comprising:

(a) a first nucleic acid molecule encoding a human antibody heavy chain having a heavy chain variable region, or an antigen-binding fragment thereof, wherein the heavy chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 85, and wherein the antigen-binding fragment comprises an N-terminal or C-terminal deletion of the amino acid sequence encoded by SEQ ID NO: 85, wherein the N-terminal or C-terminal deletion comprises SEQ ID NO: 63, SEQ ID NO: 66, and SEQ ID NO: 69; and

(b) a second nucleic acid molecule encoding a human antibody light chain.

30. A set of nucleic acid molecules comprising nucleotide sequences that encode a human antibody that specifically binds IL-1R1, comprising:

(a) a first nucleic acid molecule encoding a human antibody heavy chain; and

(b) a second nucleic acid molecule encoding a human antibody light chain having a light chain variable region, or an antigen-binding fragment thereof, wherein the light chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 86, and wherein the antigen-binding fragment comprises an N-terminal or C-terminal deletion of the amino acid sequence encoded by SEQ ID NO: 86, wherein the N-terminal or C-terminal deletion comprises SEQ ID NO: 71, SEQ ID NO: 73, and SEQ ID NO: 75.

31. A set of nucleic acid molecules comprising:

(a) a first nucleic acid molecule encoding a human antibody heavy chain having a heavy chain variable region, or an antigen-binding fragment thereof, wherein the heavy chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 85, and wherein the antigen-binding fragment comprises SEQ ID NO: 63, SEQ ID NO: 66, and SEQ ID NO: 69; and

(b) a second nucleic acid molecule encoding a human antibody light chain having a light chain variable region, or an antigen-binding fragment thereof, wherein the light chain variable region comprises the amino acid sequence encoded by SEQ ID NO: 86, and wherein the antigen-binding fragment comprises SEQ ID NO: 71, SEQ ID NO: 73, and SEQ ID NO: 75.

32. A set of nucleic acid molecules comprising:

(a) a first nucleic acid molecule comprising SEQ ID NO: 15; and

(b) a second nucleic acid molecule comprising SEQ ID NO: 17.

33. A set of nucleic acid molecules comprising:

(a) a first nucleic acid molecule comprising SEQ ID NO: 85; and

(b) a second nucleic acid molecule comprising SEQ ID NO: 86.

34. A set of vectors comprising the nucleic acid molecules of any of claims 24 - 33 , wherein one vector comprises the first nucleic acid molecule and the other vector comprises the second nucleic acid molecule.

35. A set of expression vectors comprising the nucleic acid molecules of any of claims 24 - 33 , wherein one vector comprises the first nucleic acid molecule and the other vector comprises the second nucleic acid molecule.

36. An isolated host cell comprising the set of vectors of claim 34 .

37. An isolated host cell comprising the set of expression vectors of claim 35 .

38. The host cell of either of claims 36 and 37 that is a eukaryotic cell.

39. The host cell of either of claim 36 or 37 that is a prokaryotic cell.

40. A cell line comprising the set of expression vectors of claim 35 .

Assignments (2)
MERGER Recorded Jun 2, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035767/0746 →
MERGER Recorded Aug 15, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 031016/0678 →